- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-02-0029121

RX Medmart Private Limited
About RX Medmart Private Limited
Data last updated:
RX Medmart Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 April 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52399DL2022PTC396876. Its GSTIN is 07AALCR7993R1Z1 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Hoshiyar Singh Kardam and Akshay Anilkumar Jha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 52 First Floor Dsiidc Community Work Centre Kalyanpuri, Delhi, India – 110091.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.32 Lakh, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹2.65 Lakh (net margin -4.9%) and EBITDA of -₹2.02 Lakh (EBITDA margin -3.7%).
RX Medmart Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0029121).
Company details
Recognitions & Rankings of RX Medmart
Contact details
RX Medmart Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 52 First Floor Dsiidc Community Work Centre Kalyanpuri, Delhi, India – 110091
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of RX Medmart Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of RX Medmart is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of RX Medmart Private Limited, buy the company report.
Financials of RX Medmart Private Limited
FY 2025 filings availableRX Medmart Private Limited reported revenue of ₹54.32 Lakh (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 30% in the latest year. EBITDA fell 328% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.02 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.65 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -3.7% | ||
| Net Profit Margin | -4.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of RX Medmart Private Limited, buy the company report.
Board of directors of RX Medmart Private Limited
RX Medmart has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hoshiyar Singh Kardam Also directs: Vas Spectrometers Private Limited | Director | 19 Apr 2022 | 4 Years 6 Months | Current |
| Akshay Anilkumar Jha Also directs: Vas Spectrometers Private Limited | Director | 19 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
RX Medmart Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RX Medmart Private Limitedthis company | ₹54.32 Lakh (FY 2025) | -₹2.65 Lakh | -4.9% | 30.0% | Delhi, India | |
| K B R Drug Solutions Private Limited | ₹54.28 Lakh (FY 2025) | -40.0% | Kadi, Gujarat, India | |||
| Nephcea Healthcare Private Limited | ₹54.26 Lakh (FY 2024) | 45.0% | Ghaziabad, Uttar Pradesh, India | |||
| Sperova Impex India Private Limited | ₹54.24 Lakh (FY 2024) | 130.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of RX Medmart Private Limited, buy the company report.
Auditor
RX Medmart Private Limited is audited by Sudhir Das & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sudhir Das & Associates | FY 2023 | 024913N |
Shareholding
The shareholding of RX Medmart Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of RX Medmart Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving RX Medmart Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for RX Medmart Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
RX Medmart has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCR7993R1Z1 | Delhi | Active | 05 May 2022 |
To see the full GST registrations and return filing status of RX Medmart Private Limited, buy the company report.
Recent activity
RX Medmart Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Akshay Anilkumar Jha was appointed as Director on 19 Apr 2022.
Frequently asked questions
RX Medmart is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 April 2022 (4+ years old) and is registered under CIN U52399DL2022PTC396876.
RX Medmart has 2 current directors:
- Hoshiyar Singh Kardam - Director
- Akshay Anilkumar Jha - Director
The latest financial statements of RX Medmart on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of RX Medmart is 07AALCR7993R1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of RX Medmart is U52399DL2022PTC396876. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
RX Medmart was incorporated on 19 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of RX Medmart by revenue are K B R Drug Solutions Private Limited, Nephcea Healthcare Private Limited, Sperova Impex India Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Akshay Anilkumar Jha was appointed as Director on 19 Apr 2022. Hoshiyar Singh Kardam was appointed as Director on 19 Apr 2022.
Yes, RX Medmart is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0029121).
The registered office of RX Medmart is at C – 52 First Floor Dsiidc Community Work Centre Kalyanpuri, Delhi, India – 110091.
RX Medmart operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

